Human DNA polymerase ε is a source of C>T mutations at CpG dinucleotides
C-to-T transitions in CpG dinucleotides are the most prevalent mutations in human cancers and genetic diseases. These mutations have been attributed to deamination of 5-methylcytosine (5mC), an epigenetic modification found on CpGs. We recently linked CpG>TpG mutations to replication and hypothesized that errors introduced by polymerase ε (Pol ε) may represent an alternative source of mutations. Here we present a new method called polymerase error rate sequencing (PER-seq) to measure the error spectrum of DNA polymerases in isolation. We find that the most common human cancer-associated Pol ε mutant (P286R) produces an excess of CpG>TpG errors, phenocopying the mutation spectrum of tumors carrying this mutation and deficiencies in mismatch repair. Notably, we also discover that wild-type Pol ε has a sevenfold higher error rate when replicating 5mCpG compared to C in other contexts. Together, our results from PER-seq and human cancers demonstrate that replication errors are a major contributor to CpG>TpG mutagenesis in replicating cells, fundamentally changing our understanding of this important disease-causing mutational mechanism.
Authors
- Jakub Tomek (ORCID: https://orcid.org/0000-0002-0157-4386)
- Benjamin Schuster‐Böckler (ORCID: https://orcid.org/0000-0002-8892-5133)
- Akbar Muhammed Shahid (ORCID: https://orcid.org/0000-0003-4464-8119)
- Sue Cotterill (ORCID: https://orcid.org/0000-0001-9913-0259)
- Skirmantas Kriaučionis (ORCID: https://orcid.org/0000-0002-2273-5994)
- Markéta Tomková (ORCID: https://orcid.org/0000-0001-9094-2365)
- Gilles Crevel (ORCID: https://orcid.org/0000-0002-2069-2505)
- Nandini Mozumdar
- Michael John McClellan
- Emelie Shepherd
Institutions
- St George's, University of London (GB)
- University of Oxford (GB)
- Ludwig Cancer Research (GB)
Publication Details
- Journal
- Nature Genetics
- Published
- 2024-10-10
- DOI
- https://doi.org/10.1038/s41588-024-01945-x
- Citations
- 30
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 8.55
Funders
- Conrad N. Hilton Foundation
- Wellcome
- Ludwig Institute for Cancer Research
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- Medical Research Foundation